1.Identification of the MYB transcription factor family involved in response to salt stress in Picea mongolica.
Mingming SUI ; Fuman ZHANG ; Tian TIAN ; Yanqiu YAN ; Le GENG ; Hui LI ; Yu'e BAI
Chinese Journal of Biotechnology 2025;41(2):825-844
Picea mongolica, known for its remarkable tolerance to cold, drought, and salinity, is a key species for ecological restoration and urban greening in the "Three Norths" region of China. MYB transcription factors are involved in plant responses to abiotic stress and synthesis of secondary metabolites. However, studies are limited regarding the MYB transcription factors in P. mongolica and their roles in salt stress tolerance. In this study, 196 MYBs were identified based on the genome of Picea abies and the transcriptome of P. mongolica. Phylogenetic analysis classified the MYB transcription factors into seven subclasses. The R2R3-MYB subclass contained the maximum number of genes (84.77%), while the R-R and R1R2R3 subclasses each represented the smallest proportion, at about 0.51%. The MYB transcription factors within the same subclass were highly conserved, exhibiting similar motifs and gene structures. Experiments with varying salt stress gradients revealed that P. mongolica could tolerate the salt concentration up to 1 000 mmol/L. From the transcriptome data of P. mongolica exposed to salt stress (1 000 mmol/L) for 0, 3, 6, 12, and 24 h, a total of 34 differentially expressed MYBs were identified, which suggested that these MYBs played a key role in regulating the response to salt stress. The proteins encoded by these differentially expressed genes varied in length from 89 aa to 731 aa, with molecular weights ranging from 10.19 kDa to 79.73 kDa, isoelectric points between 4.80 and 9.91, and instability coefficients from 41.20 to 70.99. Subcellular localization analysis indicated that most proteins were localized in the nucleus, while three were found in the chloroplasts. Twelve MYBs were selected for quantitative real-time PCR (qRT-PCR), which showed that their expression patterns were consistent with the RNA-seq data. This study provides valuable data for further investigation into the functions and mechanisms of MYB family members in response to salt stress in P. mongolica.
Picea/physiology*
;
Transcription Factors/classification*
;
Salt Stress/genetics*
;
Phylogeny
;
Plant Proteins/genetics*
;
Salt Tolerance/genetics*
;
Gene Expression Regulation, Plant
2.Ethical reflections on narrative wills in elderly end-of-life patients
Linan CHENG ; Fuman CAI ; Huiling LI ; Qian CHEN ; Fengying ZHANG
Chinese Medical Ethics 2025;38(6):712-717
Elderly end-of-life patients often experience distress due to being caught in dilemmas of contemplation and decision-making. Narrative wills, grounded in life values and premised on respecting individual wishes and needs, present an individual’s unique life story through narrative forms, conveying their overall experience, interpretation of meaning, and understanding of life. They are preserved and passed on in a way that meets individual expectations, thereby promoting human exploration, reflection, and growth regarding the meaning of life through interpersonal interactions that transcend space and time. This paper explored the concept of narrative wills among elderly end-of-life patients, the ethical value and ethical principles of narrative wills, and the moral and ethical risks. It also provided specific ethical interpretations, assisting in the application and development of narrative wills in elderly end-of-life patients.
3.Efficacy of ultrasound-guided thyroid injection of dexamethasone in the treatment of subacute thyroiditis
Fuman DU ; Dandan TAN ; Xiukun ZHANG ; Yanan SUN ; Jing ZHANG ; Xiaoyao YANG
Chinese Journal of Primary Medicine and Pharmacy 2025;32(1):2-6
Objective:To investigate the clinical efficacy and safety of ultrasound-guided thyroid injection of dexamethasone in the treatment of subacute thyroiditis (SAT).Methods:This is a randomized controlled study involving 32 patients with SAT who received treatment at Endocrinology Clinic of Heilongjiang Provincial Hospital between June 2022 and March 2023. The patients were randomly divided into an observation group and a control group ( n = 16 per group) using a random number table method. The observation group received ultrasound-guided injection of dexamethasone (5 mg per injection, once a week) into the thyroid lesion, while the control group was treated with oral prednisone acetate tablets (5 mg per dose, three times a day). Both groups were treated for 4 weeks. The clinical efficacy, time taken for body temperature to return to normal, time for pain resolution, time for goiter regression, time for thyroid function to normalize, as well as recurrence rates and adverse reactions, were compared between the two groups. Results:The response rate in the observation group was 100% (16/16), which was significantly higher than that in the control group [75% (12/16), χ2 = 4.57, P = 0.033]. The time taken for body temperature to return to normal, the time for goiter regression, and the time for goiter regression in the observation group were (3.5 ± 3.6) days, (7.4 ± 2.5) days, and (11.6 ± 7.4) days, respectively, which were significantly shorter than those in the control group [(6.1 ± 3.2) days, (9.9 ± 3.5) days, (16.9 ± 6.8) days, t = -2.16, -2.33, -2.11, all P < 0.05]. After 4 weeks of treatment, the observation group showed significantly lower body mass index, fasting blood glucose, and serum triglyceride levels compared to the control group ( t = -2.07, -2.46, -2.13, all P < 0.05). The recurrence rate in the observation group was 0%, which was significantly lower than that in the control group [25% (4/16), χ2 = 4.57, P = 0.033]. Conclusions:The efficacy and safety of ultrasound-guided local thyroid injection of dexamethasone for the treatment of SAT are superior to those of the oral treatment regimen.
4.Efficacy of ultrasound-guided thyroid injection of dexamethasone in the treatment of subacute thyroiditis
Fuman DU ; Dandan TAN ; Xiukun ZHANG ; Yanan SUN ; Jing ZHANG ; Xiaoyao YANG
Chinese Journal of Primary Medicine and Pharmacy 2025;32(1):2-6
Objective:To investigate the clinical efficacy and safety of ultrasound-guided thyroid injection of dexamethasone in the treatment of subacute thyroiditis (SAT).Methods:This is a randomized controlled study involving 32 patients with SAT who received treatment at Endocrinology Clinic of Heilongjiang Provincial Hospital between June 2022 and March 2023. The patients were randomly divided into an observation group and a control group ( n = 16 per group) using a random number table method. The observation group received ultrasound-guided injection of dexamethasone (5 mg per injection, once a week) into the thyroid lesion, while the control group was treated with oral prednisone acetate tablets (5 mg per dose, three times a day). Both groups were treated for 4 weeks. The clinical efficacy, time taken for body temperature to return to normal, time for pain resolution, time for goiter regression, time for thyroid function to normalize, as well as recurrence rates and adverse reactions, were compared between the two groups. Results:The response rate in the observation group was 100% (16/16), which was significantly higher than that in the control group [75% (12/16), χ2 = 4.57, P = 0.033]. The time taken for body temperature to return to normal, the time for goiter regression, and the time for goiter regression in the observation group were (3.5 ± 3.6) days, (7.4 ± 2.5) days, and (11.6 ± 7.4) days, respectively, which were significantly shorter than those in the control group [(6.1 ± 3.2) days, (9.9 ± 3.5) days, (16.9 ± 6.8) days, t = -2.16, -2.33, -2.11, all P < 0.05]. After 4 weeks of treatment, the observation group showed significantly lower body mass index, fasting blood glucose, and serum triglyceride levels compared to the control group ( t = -2.07, -2.46, -2.13, all P < 0.05). The recurrence rate in the observation group was 0%, which was significantly lower than that in the control group [25% (4/16), χ2 = 4.57, P = 0.033]. Conclusions:The efficacy and safety of ultrasound-guided local thyroid injection of dexamethasone for the treatment of SAT are superior to those of the oral treatment regimen.
5.Analysis of the metabolic regulatory mechanism of GLP-1 receptor agonist in overweight or obese patients with type 2 diabetes mellitus based on intestinal flora
Yang HU ; Fuman DU ; Yihong ZHANG
Chinese Journal of Diabetes 2024;32(12):891-897
Objective To explore the effect of GLP-1 receptor agonist (GLP-1RA) on the intestinal flora of overweight or obese patients with type 2 diabetes mellitus (T2DM). Methods 20 newly diagnosed overweight/obese T2DM patients hospitalized in our hospital from September 2022 to February 2023,were treated with GLP-1RA Liraglutide for 3 months. General data and clinical indicators were collected before and after treatment respectively. 16SrDNA high-throughput sequencing was used to detect intestinal flora in fecal samples. Results Compared with group A,body weight,BMI,TC,TG,LDL-C,SBP,FPG,HbA1c and insulin resistance index (HOMA-IR) were decreased in group B (P<0.05),islet beta cell function index (HOMA-β) and HDL-C were increased (P<0.05). There was no change in the ɑdiversity of intestinal flora (P>0.05). The β diversity showed a clustered distribution. After treatment,the abundance of Betaproteobacteria,Pasteurellales,Pasteurellaceae,Clostridiaceae,Romboutsia,Clostridium,Peptostreptococcaceae,Haemophilus,Solobacterium,Bacteroides-cellulosilyticus increased. The abundance of Burkholderiales,Enterococcaceae and Enterococcus decreased. At the genus level,the abundance of Clostridium,Haemophilus,Romboutsia and Megamonas increased (P<0.05). Conclusions GLP-1RA can not only improve glucose and lipid metabolism,β cell function and insulin sensitivity in overweight/obese T2DM patients,but can also increase the abundance of beneficial bacteria and reduce the abundance of pathogenic bacteria.
6.Analysis of the metabolic regulatory mechanism of GLP-1 receptor agonist in overweight or obese patients with type 2 diabetes mellitus based on intestinal flora
Yang HU ; Fuman DU ; Yihong ZHANG
Chinese Journal of Diabetes 2024;32(12):891-897
Objective To explore the effect of GLP-1 receptor agonist (GLP-1RA) on the intestinal flora of overweight or obese patients with type 2 diabetes mellitus (T2DM). Methods 20 newly diagnosed overweight/obese T2DM patients hospitalized in our hospital from September 2022 to February 2023,were treated with GLP-1RA Liraglutide for 3 months. General data and clinical indicators were collected before and after treatment respectively. 16SrDNA high-throughput sequencing was used to detect intestinal flora in fecal samples. Results Compared with group A,body weight,BMI,TC,TG,LDL-C,SBP,FPG,HbA1c and insulin resistance index (HOMA-IR) were decreased in group B (P<0.05),islet beta cell function index (HOMA-β) and HDL-C were increased (P<0.05). There was no change in the ɑdiversity of intestinal flora (P>0.05). The β diversity showed a clustered distribution. After treatment,the abundance of Betaproteobacteria,Pasteurellales,Pasteurellaceae,Clostridiaceae,Romboutsia,Clostridium,Peptostreptococcaceae,Haemophilus,Solobacterium,Bacteroides-cellulosilyticus increased. The abundance of Burkholderiales,Enterococcaceae and Enterococcus decreased. At the genus level,the abundance of Clostridium,Haemophilus,Romboutsia and Megamonas increased (P<0.05). Conclusions GLP-1RA can not only improve glucose and lipid metabolism,β cell function and insulin sensitivity in overweight/obese T2DM patients,but can also increase the abundance of beneficial bacteria and reduce the abundance of pathogenic bacteria.
7.Relationship between thyroid hormone level and obesity related indices in patients with type 2 diabetes mellitus
Xiaoyi ZHANG ; Fuman DU ; Liyan TAN ; Binhong DUAN ; Lei LI
Chinese Journal of Primary Medicine and Pharmacy 2023;30(3):411-415
Objective:To investigate the relationship between serum thyroid hormone levels in the normal range and body weight, blood glucose, blood lipids, and other obesity-related indexes in patients with type 2 diabetes mellitus.Methods:Seventy obese patients with type 2 diabetes mellitus and ninety-two patients with type 2 diabetes mellitus with normal weight who were treated in the Nangang Branch of Heilongjiang Provincial Hospital from May 2020 to May 2021 were included in this study. Thyroid-stimulating hormone level was in the normal range (0.35-4.94 mU/L) in all participants. Serum levels of free triiodothyronine, free thyroxine, thyroid-stimulating hormone, thyroid peroxidase antibody, thyroglobulin antibody, triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, glycosylated hemoglobin, fasting C peptide, fasting insulin, systolic blood pressure, diastolic blood pressure, and serum uric acid were measured in all participants.Results:Free triiodothyronine level was positively correlated with fasting blood glucose and glycosylated hemoglobin levels ( r = 0.19, P = 0.021; r = 0.21, P = 0.017). Free thyroxine level was positively correlated with serum glycosylated hemoglobin level ( r = 0.25, P = 0.009) and negatively correlated with total cholesterol ( r = -0.17, P = 0.029). Thyroid-stimulating hormone level was positively correlated with body mass index as well as total cholesterol and low-density lipoprotein cholesterol levels ( r = 0.33, P < 0.001; r = 0.33, P < 0.001; r = 0.32, P < 0.001). Conclusion:Thyroid hormones in the normal range play an important role in the regulation of body weight, blood glucose, and blood lipids in patients with type 2 diabetes mellitus. Blood glucose level increases markedly in patients with relatively high free triiodothyronine and free thyroxine levels. The risks of obesity and dyslipidemia increase in patients with relatively high serum thyroid-stimulating hormone levels
8.Investigation of prevalence and risk factors of depression in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention
Weimin WANG ; Fuman DU ; Yan YANG ; Hong HUO ; Lin CHE ; Xin LI ; Mingliang ZHANG
Chinese Journal of Primary Medicine and Pharmacy 2020;27(20):2491-2495
Objective:To investigate the prevalence and risk factors of depression in patients with acute ST-segment elevation myocardial infarction(STEMI) after percutaneous coronary intervention(PCI).Methods:From January 2019 to December 2019, 205 patients with STEMI who underwent PCI were selected randomly in Department of Cardiology of Heilongjiang Provincial Hospital.And 200 health examined people from our hospital at the same time were selected as health control group.The Zung self-rating depression scale(SDS) was used to score the depression in STEMI patients one week after PCI.The social demographic data were investigated, including age, gender, education status, place of residence, medical payments, monthly income, marital status, smoking history, drinking history, diabetic history, cardiovascular and cerebrovascular diseases history.The clinical indicators were measured, including height, weight, waist circumference(WC), hip circumference(HC), body mass index(BMI), waist-hip rate(WHR), fasting plasma glucose(FPG), fasting serum insulin(FINS), homeostasis model assessment-insulin resistance index(HOMA-IR), serum total cholesterol(TC), total triglyceride(TG), low density lipoprotein-C(LDL-C), high density lipoprotein-C, (HDL-C), systolic blood pressure(SBP) and diastolic blood pressure(DBP).Results:The prevalence of depression in the STEMI group was obviously higher than that in the control group(17.07% vs.9.50%, χ 2=5.025, P=0.025). There was statistically significant difference in the severity of depression between the two groups(χ 2=8.360, P=0.039). Multivariate Logistic regression analysis showed that the risk factors for depression in order of OR values were FPG, gender(female), age(65 or old), BMI, monthly income(<5 000 RMB), HOMA-IR, self-paying for medical services ( OR=1.894, 1.812, 1.545, 1.428, 1.335, 1.285, 1.202). Conclusion:The prevalence of depression in STEMI patients after PCI is increased.The risk factors for depression include female, old age, obesity, low income, insulin resistance and self-paying for medical services.
9.Genetic analysis and prenatal diagnosis of Xp deletion in a family with Duchenne/Becker muscular dystrophy.
Jing HE ; Lei WANG ; Xinhua TANG ; Bicheng YANG ; Jie SU ; Fuman JIANG ; Baosheng ZHU ; Qi ZHANG
Chinese Journal of Medical Genetics 2015;32(5):687-690
OBJECTIVE To delineate a deletional mutation of the Dystrophin gene on the short arm of chromosome X in a family affected with Duchenne/Becker muscular dystrophy. METHODS G-banded karyotyping, multiple ligation probe amplification (MLPA), array-based comparative genomic hybridization(array-CGH) and whole genome exon high-throughput sequencing were employed to delineate the mutation in the family. RESULTS GTG banding has demonstrated deletion of the terminal part of the short arm of chromosome X in the fetus. The same deletion was also found in its mother and maternal grandmother. MLPA analysis has revealed removal of exons 52 to 79 of the Dystrophin gene. A 30 Mb deletion in Xp22.33-p21.1 and a 10 Mb duplication in Xq27.2-q28 were identified by array-CGH and whole genome exon high-throughput sequencing. CONCLUSION The Xp deletion has led to deletion of exons 52 to 79 of the Dystrophin gene in the family. The female carriers also had certain features of Turner syndrome due to the same deletion.
Chromosome Deletion
;
Chromosomes, Human, X
;
Female
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Muscular Dystrophy, Duchenne
;
diagnosis
;
genetics
;
Nucleic Acid Amplification Techniques
;
Pregnancy
;
Prenatal Diagnosis
10.Effects of Buyang Huanwu Decoction on L-type Calcium Channels of Cortical Neurons in Rats with Global Cerebral Ischemia and Reperfusion at Different Time Points
Li GUAN ; Fuman YAN ; Xiaodong ZHANG ; Wen SU ; Xiaoying LI ; Lequan ZHOU ; Rongjing LUO
Journal of Guangzhou University of Traditional Chinese Medicine 2001;0(03):-
【Objective】 The effect of pretreatment with Buyang Huanwu Decoction(BHD) on L-type calcium channels of cortical neurons in rats with global cerebral ischemia was observed,thus to explore the molecular therapeutic mechanism of BHD for cerebral ischemia as well as the pathogenic mechanism of Ca2+ message in ischemic injury of neurons.【Methods】SD rats were randomized into pseudo-operation group,model groups and BHD groups.And the model groups and BHD groups were divided into six groups according to the time points after reperfusion(2nd,12th,24th,48th and 72nd hour after reperfusion respectively).BHD groups received 0.64g/kg BHD by gastric infusion,bid,for 5 continuous days.Except the rats in pseudo-operation groups,the rats in other groups were induced global cerebral ischemia by modified Pulsinelli's four-vessel occlusion.Cerebral cortical neurons in rats were isolated promptly in 2nd,12th,24th,48th and 72nd hour after reperfusion.The recorded single-channel current was amplified by the EPC-9 patch-clamping amplifier,and then input into the computer by Pulse+Pulsefit.The analytical software TAC was used to detect the opening time and opening probability of the L-type Ca2+ channels in rats at different time points after reperfusion.【Results】In the model groups,the opening time of the L-type Ca2+ channels was prolonged after reperfusion as compared with that in the pseudo-operation group,and the opening probability of the L-type Ca2+ channels arrived at the peaks in 2nd and 24th hour after reperfusion.In BHD groups,the opening time in 72nd hour after reperfusion was decreased(P

Result Analysis
Print
Save
E-mail